gynaecological cancers A randomized, double-blind phase 3 trial of maintenance therapy with niraparib vs placebo in patients with platinum-sensitive recurrent ovarian cancer (ENGOT-OV16/NOVA trial)

Journal article

Open access

Peer reviewed

M.R. Mirza, B.J. Monk, A. Oza, S. Mahner, A. Redondo, M. Fabbro, J. Ledermann, D. Lorusso, I.B. Vergote, O. Rosengarten, …

Annals of oncology, Vol.27, pp.vi568-vi568

10/01/2016

Files and links (1)

url

https://doi.org/10.1093/annonc/mdw435.26View

Published (Version of record) Open

1 Record Views

Title: gynaecological cancers A randomized, double-blind phase 3 trial of maintenance therapy with niraparib vs placebo in patients with platinum-sensitive recurrent ovarian cancer (ENGOT-OV16/NOVA trial)
Creators: M.R. Mirza - Copenhagen University Hospital
B.J. Monk - University of Arizona
A. Oza - University Health Network
S. Mahner - Ludwig Maximilian University of Munich
A. Redondo - Hospital Universitario HM Madrid
M. Fabbro - Institute of Cancer Research of Montpellier
J. Ledermann - University College London
D. Lorusso - Fondazione IRCCS Istituto Nazionale dei Tumori
I.B. Vergote - KU Leuven
O. Rosengarten - Shaare Zedek Medical Center
J. Berek - 11Department of Oncology, Stanford Women's Cancer Center, Stanford, CA, USA
J. Herrstedt - Odense University Hospital
A.V. Tinker - BC Cancer Agency
A. Dubois - Kliniken Essen-Mitte
A. Gonzalez Martin - MD Anderson Cancer Center Madrid
P. Follana - Centre Antoine Lacassagne
B. Benigno - Gynecologic Oncology Group
B.J. Rimel - Cedars-Sinai Medical Center
S. Agarwal - Tesaro
U. Matulonis - Dana-Farber Cancer Institute
Publication Details: Annals of oncology, Vol.27, pp.vi568-vi568
Publisher: Elsevier Ltd
Identifiers: 991005969006102656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article